Novonesis (Novozymes) B
NSISBC
Kedudukan dalam Saham
#1148
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Harga Saham
$70.90
Modal Pasaran
$19.70B
Perubahan (1 hari)
1.14%
Perubahan (1 tahun)
11.82%
Negara
DK
Perdagangan Novonesis (Novozymes) B (NSISBC)
Kategori
Basic Materials
Bilangan saham terbitan bagi Novonesis (Novozymes) B (NSISBC)
Bilangan saham terbitan setakat October 2026: 0
Menurut laporan kewangan terkini dan harga saham Novonesis (Novozymes) B, bilangan saham terbitan semasa ialah 0. Pada akhir October 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Novonesis (Novozymes) B (NSISBC) dari 2019 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2025 | 466.88M | 68.00% |
| 2024 | 277.90M | 0.01% |
| 2023 | 277.87M | -0.29% |
| 2022 | 278.70M | -0.52% |
| 2021 | 280.14M | -0.64% |
| 2020 | 281.94M | -1.58% |
| 2019 | 286.47M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 462.53M | - |
GB
|
|
| - | - |
FR
|
|
| 244.80M | - |
US
|
|
| 281.30M | - |
US
|
|
| 222.80M | - |
US
|
